Search

for
Search:

Glossary Dystrophic Anagen Effluvium

hair loss from damaged growth-phase follicles, often due to chemotherapy

Dystrophic Anagen Effluvium refers to a type of hair loss that occurs when hair follicles in the anagen (growth) phase are damaged, often due to chemotherapy or radiation therapy. This damage leads to the production of weakened, brittle hair that breaks easily, resulting in rapid and significant hair shedding.

Related Terms

Research

5 / 1000+ results

research Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy

2 citations , March 2015 in “Hepatitis Monthly”

This case report identified dystrophic anagen effluvium as a previously unreported dermatological side effect of PEG-INF-α-2a/RBV combination therapy in a patient with chronic hepatitis C infection.

Anagen Effluvium Due to Thallium Poisoning from Chinese Herbal Medicine and Rodenticide Containing Thallium Salts

research Anagen effluvium due to thallium poisoning derived from the intake of Chinese herbal medicine and rodenticide containing thallium salts

5 citations , June 2015 in “Journal of dermatology”

This letter to the editor describes a case of anagen effluvium due to thallium poisoning from Chinese herbal medicine and rodenticide but reports no new research findings.

research Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita

31 citations , October 2010 in “Journal of the European Academy of Dermatology and Venereology”

The authors concluded that some patients clinically diagnosed with telogen effluvium may actually have alopecia areata incognita, suggested by the presence of dystrophic hairs and development of alopecia patches.

research Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium

December 2021 in “Journal of The American Academy of Dermatology”

This article discusses post-COVID-19 hair loss, highlighting potential misdiagnoses between different types and the expanded role of dermatologists; no new clinical findings are reported.

Clinical and Histological Challenge in the Differential Diagnosis of Diffuse Alopecia: Female Androgenetic Alopecia, Telogen Effluvium and Alopecia Areata – Part I

research Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata – part I

29 citations , October 2012 in “Anais Brasileiros De Dermatologia”

This review presents an objective analysis of female androgenetic alopecia, discussing clinical and dermoscopic examination approaches but reports no new clinical findings.

View more "dystrophic anagen effluvium" in research →

Community Join

2 / 1000+ results

community PP405 Won't Work Long Term: Hair Follicle Damage Due to Abuse of the ISR System

67 upvotes 11 months ago

PP405 may damage hair follicles if used long-term, suggesting cycling might be necessary. Combining it with finasteride could help maintain hair growth.

community PP405 vs Hair Cloning – Which Would Be Better for NW7 to NW1?

in Research/Science 20 upvotes 1 year ago

PP405 and hair cloning are discussed as potential treatments for reversing hair loss from Norwood 7 to Norwood 1. Hair cloning is seen as a more permanent solution, while PP405's effectiveness and long-term effects remain uncertain.

View more "dystrophic anagen effluvium" in community →

Clinics

6 / 14 results

All 14 clinic results →

Learn

— no results

Try a deeper search in learn →

Experts

— no results

Try a deeper search in experts →